Justin Porter, MD
Interventional Pain Medicine · Oklahoma City, OKNPI 1104098961
Payments from drug & device makers
Across 411 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Nevro Corp.$2K
- Medtronic$689
- Globus Medical$408
- AbbVie$325
- Amgen$322
- plus $1K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 196 | $2,508 |
| Nevro Corp. | 62 | $2,077 |
| Medtronic(2 entities) | 36 | $689 |
| Globus Medical | 13 | $408 |
| AbbVie(2 entities) | 18 | $325 |
| Amgen(2 entities) | 20 | $322 |
| Scilex Pharmaceuticals Inc. | 16 | $248 |
| Boston Scientific | 4 | $175 |
| Stryker | 1 | $153 |
| Vertos Medical, Inc. | 1 | $69 |
| SPR Therapeutics, Inc | 8 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $63 |
| GRT US Holding, Inc. | 4 | $60 |
| Vertiflex, Inc. | 2 | $54 |
| Saluda Medical Americas, Inc. | 3 | $53 |
| Pacira Therapeutics, Inc. | 3 | $47 |
| Avanos Medical | 2 | $45 |
| Pfizer | 3 | $34 |
| Almatica Pharma LLC | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Si-bone, Inc. | 1 | $27 |
| Zyla Life Sciences, Inc. | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Forte Bio-pharma LLC | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Bioventus LLC | 1 | $16 |
| Merck | 1 | $15 |
| Nalu Medical, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $13 |
How this compares
$7,676 in reported general payments places this provider in the 85th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Oklahoma City
- Brandon ValantineOklahoma City$9K
- Blake ChristensenOklahoma City$6K
- Shawn EllisOklahoma City$6K
- Nathan OverbeyOklahoma City$5K
- Ahmed AmayemOklahoma City$5K
- Peyton JohnsonOklahoma City$5K
- Patrick PrevoOklahoma City$4K
- Arthur BeachamOklahoma City$4K
- Timothy CramerOklahoma City$3K
- Sanaa KarimOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.